Biotech Series A Investors & VC Firms
1626 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.
Manta Ray Ventures
LondonPre-Seed–Growth
8 people
Perot Jain
DallasPre-Seed–Series A$500K
4 people
AgFunder
San FranciscoSeed–Series C$10K – $5M
23 people
AME Cloud Ventures
Palo AltoSeed–Late Stage$1M – $10M
11 people
HTGF
BonnPre-Seed–Series A$1.1M
37 people
Chalmers Ventures AB
GöteborgPre-Seed–Series A$21.6M
24 people
New World Angels
Boca RatonSeed–Series A
54 people
S32
Palo AltoSeries A–Late Stage
30 people
Johnson & Johnson Innovation – JJDC
New BrunswickSeed–Growth
42 people
Pfizer Venture Investments
Seed–Late Stage$5M – $20M
16 people
Taiwania Capital
TaipeiSeed–Growth
49 people
Lightstone Ventures
Portola ValleyPre-Seed–Series C
31 people
Illumina Ventures
Foster CitySeed–Series A
40 people
redalpine
ZugSeed–Growth$108K – $2.2M
28 people
ACME Capital
San FranciscoPre-Seed–Growth
13 people
b2venture
BerlinPre-Seed–Series B$270K – $5.4M
36 people
OMERS Ventures
TorontoPre-Seed–Series C$5M – $25M
15 people
Sanofi Ventures
CambridgeSeed–Series B$5M
20 people
M Ventures
AmsterdamSeed–Growth$10.8M
12 people
SR One Capital Management
Redwood CitySeed–Series B
30 people
Hyundai Venture Investment Corporation
SeoulSeed–Series B$500K – $2M
Eurazeo
ParisSeed–Late Stage
35 people
OneVentures
SydneySeed–Growth$3.3M – $13.2M
40 people
Arboretum Ventures
Ann ArborSeed–Series A$5M – $15M
28 people
Related lists
Series A Investors & VC Firms (7326)Series A Investors & VC Firms in North America (4220)Series A Investors & VC Firms in United States (3839)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2591)Biotech Investors & VC Firms (2475)Series A Investors & VC Firms in Europe (2384)Fintech Series A Investors & VC Firms (2350)Healthtech Series A Investors & VC Firms (2310)Enterprise Software Series A Investors & VC Firms (2265)
Data sourced from public filings and firms' own websites — see our methodology.













































































































